Physician

Adam Seth Bodzin, M.D.

According to 2025 Medicare claims, Adam Bodzin, M.D. (NPI: 1366651416) practices general surgery in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is JEFFERSON UNIVERSITY PHYSICIANS (NPI: 1326093675; TIN: 232809585) and primary practice location at 19107-4824. Bodzin is affiliated with the Delaware Valley ACO (ACO ID: A2024) and UCMCNACO, LLC (ACO ID: A3531), participating under the MSSP model.

Bodzin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 51 traditional Medicare patients, billed 135 HCPCS/CPT codes, and received $36,699 in Medicare payments. The top billing code was 99232 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes). Part D data shows 272 prescription claims across 23 beneficiaries totaling $42,188 in drug costs, led by Lokelma (Sodium Zirconium Cyclosilicate). DME data shows 43 claims. Open Payments data shows 6 records totaling $18,000. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $19,565 and ending at $36,699. Concurrently, Part D prescription costs have risen steadily, from $4,746 to $42,188. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	40	86	$19,565
2016	63	270	$70,461
2017	87	193	$42,930
2018	78	155	$45,879
2019	120	403	$88,781
2020	84	346	$60,450
2021	93	295	$74,930
2022	77	276	$73,412
2023	58	177	$55,045
2024	51	135	$36,699

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	33	$4,746
2016	12	81	$32,097
2017	15	116	$18,438
2018	15	79	$22,936
2019	33	238	$27,434
2020	26	349	$43,878
2021	37	315	$51,079
2022	29	297	$56,781
2023	29	275	$60,485
2024	23	272	$42,188

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	117	$11,213
2017	N/R	151	$11,664
2018	N/R	53	$5,896
2019	N/R	77	$4,819
2020	N/R	38	$2,422
2021	N/R	84	$5,137
2022	N/R	37	$1,766
2023	N/R	88	$2,744
2024	N/R	43	$1,209

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	21	73	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lokelma	Sodium Zirconium Cyclosilicate	11	390	$10,107
Valganciclovir Hcl	Valganciclovir Hcl	29	930	$8,498
Tacrolimus	Tacrolimus	14	540	$3,441
Gabapentin	Gabapentin	27	1,050	$322
Pantoprazole Sodium	Pantoprazole Sodium	28	1,140	$139

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	12	$714
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	18	$320
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	13	$176

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$18,000	TransMedics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Seth Bodzin, M.D.?

Tedicare shows public-source Medicare data for Adam Seth Bodzin, M.D. (NPI 1366651416), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Seth Bodzin, M.D. have ACO affiliation data?

Adam Seth Bodzin, M.D. is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024) and UCMCNACO, LLC (MSSP, ACO ID A3531).

What billing organization is linked to Adam Seth Bodzin, M.D.?

Adam Seth Bodzin, M.D. is linked to JEFFERSON UNIVERSITY PHYSICIANS (billing NPI 1326093675) in the available physician profile data.

Does Adam Seth Bodzin, M.D. have Open Payments data?

Adam Seth Bodzin, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.